Login
$NGNE
$26.99 +$3.45 (14.66%) Close

$NGNE SEC Filings

Filed On Filing
07 Oct 2026 SCHEDULE 13G
06 Oct 2026 SCHEDULE 13G
02 Oct 2026 Form 4: McMinn Rachel, Director

Received 756 shares by exercise or conversion ($19.1K)

14 Aug 2026 SCHEDULE 13G/A
14 Aug 2026 SCHEDULE 13G/A
14 Aug 2026 SCHEDULE 13G
11 Aug 2026 10-Q
11 Aug 2026 8-K: Results of Operations and Financial Condition
07 Jul 2026 Form 4: Cvijic Christine Mikail, Director

Sold 600 shares ($21.6K) · Sold 4,200 shares ($152K)

02 Jul 2026 Form 4: Cvijic Christine Mikail, Director

Sold 739 shares ($25.2K) · Sold 4,061 shares ($141K)

02 Jul 2026 424B5
02 Jul 2026 8-K: Entry into a Material Definitive Agreement; Other Events
30 Jun 2026 424B5
29 Jun 2026 8-K: Regulation FD Disclosure; Other Events
16 Jun 2026 Form 4/A: Woods Keith, Director

Granted 15,400 Stock Option (Right to Buy)

16 Jun 2026 Form 4/A: Woods Keith, Director

Granted 7,700 Stock Option (Right to Buy)

16 Jun 2026 Form 4/A: Woods Keith, Director

Granted 12,050 Non-Qualified Stock Option (right to buy)

16 Jun 2026 Form 3/A: Woods Keith, Director

No securities owned

08 Jun 2026 8-K: Regulation FD Disclosure
04 Jun 2026 8-K: Submission of Matters to a Vote of Security Holders

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support